Phase 2 Open-Label Study of Sacituzumab Govitecan as Second-Line Therapy in Patients With Extensive-Stage SCLC: Results From TROPiCS-03

作者：Afshin Dowlati, Anne C. Chiang, Andrés Cervantes, Sunil Babu, Erika Hamilton, Shu Fen Wong, Andrea Tazbirkova, Ivana Sullivan, Cédric van Marcke, Antoîne Italiano, Jilpa Patel, Sabeen Mekan, Tia Wu, Saiama N. Waqar · 发表于：Journal of Thoracic Oncology · 年份：2025 · DOI：10.1016/j.jtho.2024.12.028 · 被引用次数：51 · 研究领域：Lung Cancer Research Studies、PARP inhibition in cancer therapy、Advanced Breast Cancer Therapies